This inventor holds 3 USPTO granted patents. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2002-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2002)
- Shinjuku-ku, JP (2005 - 2009)
Company Filing History:
Years Active: 2002-2009
Title: Kazuyuki Matsuura: Innovator in Respiratory Disease Treatment
Introduction
Kazuyuki Matsuura is a notable inventor based in Shinjuku-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases. With a total of 3 patents to his name, Matsuura's work has the potential to impact many lives.
Latest Patents
Matsuura's latest patents include an agent for treating respiratory diseases that contains a 4-hydroxypiperidine derivative as an active ingredient. This innovative agent is designed to prevent and treat various respiratory conditions, including lung cancer, common cold syndrome, pulmonary tuberculosis, pneumonia, acute bronchitis, and chronic bronchitis. The compound exhibits excellent antitussive activity, making it a valuable addition to respiratory disease treatments. Another significant patent involves 4-hydroxypiperidine derivatives that possess analgesic activity. This compound is also represented by a specific formula and is intended for use in pharmaceutical compositions.
Career Highlights
Kazuyuki Matsuura is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to develop groundbreaking treatments. His work is characterized by a strong focus on innovative solutions for complex health issues.
Collaborations
Matsuura has collaborated with esteemed colleagues, including Yasushige Akada and Kiyoshi Mizuguchi. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.
Conclusion
Kazuyuki Matsuura's contributions to the field of respiratory disease treatment through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for advancements in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile